<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04924426</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0283</org_study_id>
    <nct_id>NCT04924426</nct_id>
  </id_info>
  <brief_title>Interest of TTC for the Early Diagnosis of Acute Myocardial Infarction at Autopsy</brief_title>
  <acronym>INFARCTOPSY</acronym>
  <official_title>Interest of Triphenyl Tetrazolium Chloride (TTC) for the Early Diagnosis of Acute Myocardial Infarction at Autopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ischemic heart disease is the leading cause of death worldwide and the leading cause of&#xD;
      sudden cardiac death. However, its post-mortem diagnosis is particularly difficult because&#xD;
      the gross examination of the heart is usually normal at the autopsy . The diagnosis is&#xD;
      therefore often based on a set of indirect arguments, such as the patient's medical and&#xD;
      clinical history and the degree of occlusion of the coronary arteries. The formal diagnosis&#xD;
      of acute myocardial infarction (AMI) currently relies on standard histological examination.&#xD;
      However, histological findings often require a prolonged survival time of several hours to be&#xD;
      highlighted. Triphenyltetrazolium chloride (TTC) is a salt that reacts with lactate&#xD;
      dehydrogenases contained in still viable myocardial cells, forming a red pigment visible to&#xD;
      the naked eye, (1,3,5 triphenylformazan). Ischemia-induced cell death, which occurs within&#xD;
      minutes of the causative event, is responsible for the leakage of lactate deshydrogenase into&#xD;
      the extracellular medium and thus results in the absence of formazan formation in the&#xD;
      infarcted area, which displays an easily identifiable pale unstained color. It has been&#xD;
      suggested that the use of TTC would allow the identification of MI as early as one hour of&#xD;
      survival in animal models, before the usual macroscopic and microscopic signs are visible. It&#xD;
      could therefore represent an attractive forensic tool for the early diagnosis of AMI at the&#xD;
      autopsy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Anticipated">August 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Negative colorimetric reaction to TTC of infarcted myocardial tissue</measure>
    <time_frame>day 1</time_frame>
    <description>Negative colorimetric reaction to TTC of infarcted myocardial tissue</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival time (time from initial symptoms to death)</measure>
    <time_frame>day 1</time_frame>
    <description>Survival time (time from initial symptoms to death)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-mortem interval (time from death to autopsy)</measure>
    <time_frame>day 1</time_frame>
    <description>Post-mortem interval (time from death to autopsy)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Patients with AMI</arm_group_label>
    <description>Patients with AMI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with no AMI</arm_group_label>
    <description>Patients with no AMI</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TTC immersion</intervention_name>
    <description>TTC immersion</description>
    <arm_group_label>Patients with AMI</arm_group_label>
    <arm_group_label>Patients with no AMI</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      myocardial fragments&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Suspicion of death due to acute myocardial infarction&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Adult patients autopsied at the Forensic Institute of the CHU of MONTPELLIER whose&#xD;
             ante-mortem (medical history, cardiovascular risk factors, clinical history) and&#xD;
             autopsy data (significant coronary stenosis associated or not with an endoluminal&#xD;
             thrombus, scars of old infarction, absence of other identified cause of death) suggest&#xD;
             AMI as the cause of death.&#xD;
&#xD;
          -  Known survival time and postmortem interval.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        - Putrefied bodies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre-Antoine Peyron, PH</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Manon Blanc, resident</last_name>
    <phone>06-15-63-14-58</phone>
    <phone_ext>33</phone_ext>
    <email>ma-blanc@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manon BLANC, resident</last_name>
      <phone>06-15-63-14-58</phone>
      <phone_ext>33</phone_ext>
      <email>ma-blanc@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 10, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2021</study_first_posted>
  <last_update_submitted>June 10, 2021</last_update_submitted>
  <last_update_submitted_qc>June 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Early Acute Myocardial Infarction</keyword>
  <keyword>TTC</keyword>
  <keyword>Sudden death</keyword>
  <keyword>Early markers</keyword>
  <keyword>biochemicla markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

